Behavioral and physiological effects of acute ketamine exposure in adult zebrafish

Neurotoxicology and Teratology

Volumn 33, Issue 6, 2011, Pages 658-667

  Riehl, Russell ^a   Kyzar, Evan ^a   Allain, Alexander ^a   Green, Jeremy ^a   Hook, Molly ^a   Monnig, Louis ^a   Rhymes, Kate ^a   Roth, Andrew ^a   Pham, Mimi ^a   Razavi, Roshan ^a   DiLeo, John ^a   Gaikwad, Siddharth ^a   Hart, Peter ^a   Kalueff, Allan V ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Aquatic models; Behavioral testing; C fos expression; Cortisol; Locomotion and circling

Indexed keywords

HYDROCORTISONE; KETAMINE;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BRAIN LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIVITY; EVOKED RESPONSE; FEMALE; GENE EXPRESSION; GENE LOCATION; HABITUATION; LOCOMOTION; MALE; NEUROTOXICITY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SWIMMING; ZEBRA FISH;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GENE EXPRESSION; HIGH-THROUGHPUT SCREENING ASSAYS; HYDROCORTISONE; KETAMINE; MALE; MOTOR ACTIVITY; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, N-METHYL-D-ASPARTATE; VIDEO RECORDING; ZEBRAFISH;

ANIMALIA; DANIO RERIO; RODENTIA;

EID: 84855955477     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.05.011     Document Type: Article

References (94)

1. Abramson H.A., Gettner H.H., Hewitt M.P., Dean G. Effect of lysergic acid diethylamide on the surfacing behaviour of large carp. Nature 1962, 193:320-321.
2. Aguado L., San Antonio A., Perez L., del Valle R., Gomez J. Effects of the NMDA receptor antagonist ketamine on flavor memory: conditioned aversion, latent inhibition, and habituation of neophobia. Behav Neural Biol 1994, 61:271-281.
3. Al-Hamdani A.H., Ebrahim S.K., Mohammad F.K. Experimental xylazine-ketamine anesthesia in the common carp Cyprinus carpio. J Wildl Dis 2010, 46:596-598.
4. Ali S.F., Kordsmeier K.J., Gough B. Drug-induced circling preference in rats. Correlation with monoamine levels. Mol Neurobiol 1995, 11:145-154.
5. Amann L.C., Halene T.B., Ehrlichman R.S., Luminais S.N., Ma N., Abel T., et al. Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials. Neurobiol Dis 2009, 35:311-317.
6. Ando Y., Hojo M., Kanaide M., Takada M., Sudo Y., Shiraishi S., et al. S(+)-Ketamine suppresses desensitization of gamma-aminobutyric acid type B receptor-mediated signaling by inhibition of the interaction of gamma-aminobutyric acid type B receptors with g protein-coupled receptor kinase 4 or 5. Anesthesiology 2011, 114:401-411.
7. Arslanova D., Yang T., Xu X., Wong S.T., Augelli-Szafran, Xia W. Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors. BMC Biotechnol 2010, 10(24).
8. Becker A., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1267-1277.
9. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:687-700.
10. Bencan Z., Sledge D., Levin E.D. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 2009, 94:75-80.
11. Bennett D.A., Bernard P.S., Amrick C.L. A comparison of PCP-like compounds for NMDA antagonism in two in vivo models. Life Sci 1988, 42:447-454.
12. Benturquia N., Courtin C., Noble F., Marie-Claire C. Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. Brain Res 2008, 1211:1-5.
13. Braida D., Limonta V., Pegorini S., Zani A., Guerini-Rocco C., Gori E., et al. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology (Berl) 2007, 190:441-448.
14. Brown T.C., Cole W.H., Murray G.H. Ketamine: a new anaesthetic agent. Aust N Z J Surg 1970, 39:305-310.
15. Burgess H.A., Granato M. Sensorimotor gating in larval zebrafish. J Neurosci 2007, 27:4984-4994.
16. Cachat J., Canavello P., Elegante M., Bartels B., Hart P., Bergner C., et al. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 2010, 208:371-376.
17. Cachat J., Stewart A., Grossman L., Gaikwad S., Kadri F., Chung K.M., et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc 2010, 5:1786-1799.
18. Cachat J., Stewart A., Grossman L., Gaikwad S., Kadri F., Min Chung K., et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc 2010, 5:1786-1799.
19. Canever L., Oliveira L., D'Altoe de Luca R., Correa P.T., D.de B.F., Matos M.P., et al. A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes. Oxid Med Cell Longev 2010, 3:421-427.
20. Canever L., Oliveira L., Luca R.D., Correa P.T., Fraga D.D., Matos M.P., et al. A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes. Oxid Med Cell Longev 2010, 3.
21. Chen J., Patel R., Friedman T.C., Jones K.S. The behavioral and pharmacological actions of NMDA receptor antagonism are conserved in zebrafish larvae. Int J Comp Psychol 2010, 23:82-90.
22. Cox J.A., Kucenas S., Voigt M.M. Molecular characterization and embryonic expression of the family of N-methyl-D-aspartate receptor subunit genes in the zebrafish. Dev Dyn 2005, 234:756-766.
23. Crisp T., Perrotti J.M., Smith D.L., Stafinsky J.L., Smith D.J. The local monoaminergic dependency of spinal ketamine. Eur J Pharmacol 1991, 194:167-172.
24. de Mello C.F., Begnini J., Jimenez-Bernal R.E., Rubin M.A., de Bastiani J., da Costa E., et al. Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms. Brain Res 1996, 721:120-125.
25. Dickerson D., Pittman B., Ralevski E., Perrino A., Limoncelli D., Edgecombe J., et al. Ethanol-like effects of thiopental and ketamine in healthy humans. J Psychopharmacol 2010, 24:203-211.
26. Durieux M.E. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg 1995, 81:57-62.
27. Echevarria D.J., Hammack C.M., Pratt D.W., Hosemann J.D. A novel behavioral test battery to assess global drug effects using the zebrafish. Int J Compar Psychol 2008, 21:19-34.
28. Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009, 205:38-44.
29. Engin E., Treit D., Dickson C.T. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience 2009, 161:359-369.
30. Eshel Y., Korczyn A.M. Circling behavior induced by phencyclidine in mice and its inhibition by naloxone. Experientia 1985, 41:73-74.
31. Finck A.D., Ngai S.H. Opiate receptor mediation of ketamine analgesia. Anesthesiology 1982, 56:291-297.
32. Gao X.M., Elmer G.I., Adams-Huet B., Tamminga C.A. Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs. Pharmacol Biochem Behav 2009, 92:236-242.
33. Gettner H.H., Rolo A., Abramson H.A. Lysergic acid diethylamide (Lsd-25). Xxxv. Comparison of effect on Siamese fighting fish and goldfish. J Psychol 1964, 58:57-63.
34. Gonzalez-Maeso J., Ang R.L., Yuen T., Chan P., Weisstaub N.V., Lopez-Gimenez J.F., et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008, 452:93-97.
35. Grossman L., Utterback U., Stewart A., Gaikwad S., Wong K., Elegante M., et al. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 2010, 214:277-284.
36. Grove D.J. The effects of adrenergic drugs on melanophores of the minnow, Phoxinus phoxinus L. Comp Biochem Physiol 1969, 28:37-54.
37. Haggerty G.C., Forney R.B., Johnson J.M. The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period. Toxicol Appl Pharmacol 1984, 75:444-453.
38. Hall R., Murdoch J. Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection. Can J Anaesth 1990, 37:762-777.
39. Hetzler B.E., Wautlet B.S. Ketamine-induced locomotion in rats in an open-field. Pharmacol Biochem Behav 1985, 22:653-655.
40. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86:6-19.
41. Hortopan G.A., Dinday M.T., Baraban S.C. Zebrafish as a model for studying genetic aspects of epilepsy. Dis Model Mech 2010, 3:144-148.
42. Hustveit O., Maurset A., Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol 1995, 77:355-359.
43. Inta D., Trusel M., Riva M.A., Sprengel R., Gass P. Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications. Int J Neuropsychopharmacol 2009, 12:1133-1136.
44. Irifune M., Sato T., Kamata Y., Nishikawa T., Dohi T., Kawahara M. Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg 2000, 91:230-236.
45. Irons T.D., MacPhail R.C., Hunter D.L., Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 2010, 32:84-90.
46. Kalueff A., Nutt D.J. Role of GABA in memory and anxiety. Depress Anxiety 1996, 4:100-110.
47. Kalueff A.V., Jensen C.L., Murphy D.L. Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Res 2007, 1169:87-97.
48. Kily L.J., Cowe Y.C., Hussain O., Patel S., McElwaine S., Cotter F.E., et al. Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways. J Exp Biol 2008, 211:1623-1634.
49. Koros E., Rosenbrock H., Birk G., Weiss C., Sams-Dodd F. The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats. Neuropsychopharmacology 2007, 32:562-576.
50. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
51. Krystal J.H., Perry E.B., Gueorguieva R., Belger A., Madonick S.H., Abi-Dargham A., et al. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 2005, 62:985-994.
52. Lefebvre K.A., Tilton S.C., Bammler T.K., Beyer R.P., Srinouanprachan S., Stapleton P.L., et al. Gene expression profiles in zebrafish brain after acute exposure to domoic acid at symptomatic and asymptomatic doses. Toxicol Sci 2009, 107:65-77.
53. Levin E.D., Cerutti D.T. Chapter 15: Behavioral Neuroscience of Zebrafish. Methods of Behavior Analysis in Neuroscience 2009, CRC Press, Boca Raton(FL). 2nd ed. J.J. Buccafusco (Ed.).
54. Li N., Liu R.J., Dwyer J.M., Banasr M., Lee B., Son H., et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011.
55. Lieschke G.J., Currie P.D. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007, 8:353-367.
56. Lopez-Patino M.A., Yu L., Cabral H., Zhdanova I.V. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 2008, 93:160-171.
57. Maximino C., da Silva A.W., Gouveia A., Herculano A.M. Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog Neuropsychopharmacol Biol Psychiatry 2011.
58. Maxwell C.R., Ehrlichman R.S., Liang Y., Trief D., Kanes S.J., Karp J., et al. Ketamine produces lasting disruptions in encoding of sensory stimuli. J Pharmacol Exp Ther 2006, 316:315-324.
59. Moore J.W., Turner D.C., Corlett P.R., Arana F.S., Morgan H.L., Absalom A.R., et al. Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia. Cogn Neuropsychiatry 2011, 1-18.
60. Murata S., Kawasaki K. Common and uncommon behavioural effects of antagonists for different modulatory sites in the NMDA receptor/channel complex. Eur J Pharmacol 1993, 239:9-15.
61. Myslobodsky M., Ackermann R.F., Mansour R., Golovchinsky V. Ketamine-induced rotation and its interaction with naloxone in rats. Brain Res 1979, 172:191-195.
62. Myslobodsky M.S., Ackermann R.F., Golovchinsky V., Engel J. Ketamine-induced rotation: interaction with GABA-transaminase inhibitors and picrotoxin. Pharmacol Biochem Behav 1979, 11:483-486.
63. Navarro J.F., Rivera A., Maldonado E., Cavas M., de la Calle A. Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:249-254.
64. Neill J.C., Barnes S., Cook S., Grayson B., Idris N.F., McLean S.L., et al. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 2010.
65. NIDA Hallucinogens and dissociative drugs, Editor's Edition, NIH, Bethesda, MD 2010.
66. Peng S., Zhang Y., Ren B., Zhang J., Wang H. Effect of ketamine administration on memory consolidation, p-CREB and c-fos expression in the hippocampal slices of minor rats. Mol Biol Rep 2010.
67. Reissig C.J., Rabin R.A., Winter J.C., Dlugos C.A. d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex. Eur J Pharmacol 2008, 583:40-47.
68. Ricci V., Martinotti G., Gelfo F., Tonioni F., Caltagirone C., Bria P., et al. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology (Berl) 2010.
69. Sanchez B.C., Ralston-Hooper K., Sepulveda M.S. Review of recent proteomic applications in aquatic toxicology. Environ Toxicol Chem 2011, 30:274-282.
70. Silvestre J.S., Nadal R., Pallares M., Ferre N. Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 1997, 5:29-33.
71. Speedie N., Gerlai R. Alarm substance induced behavioral responses in zebrafish Danio rerio. Behav Brain Res 2008, 188:168-177.
72. Spence R., Gerlach G., Lawrence C., Smith C. The behaviour and ecology of the zebrafish, Danio rerio. Biol Rev Camb Philos Soc 2008, 83:13-34.
73. Stewart A., Kadri F., DiLeo J., Chung K., Cachat J., Goodspeed J., et al. The developing utility of zebrafish in modeling neurobehavioral disorders. International Journal of Comparative Psychology 2010, 23:104-121.
74. Stewart A., Riehl R., Wong K., Green J., Cosgrove J., Vollmer K., Kyzar E., Hart P., Allain A. J. Cachat and others, Behavioral effects of MDMA ("Ecstasy") on adult zebrafish. Behav Pharmacol 2011, 22(3):275-280.
75. Stewart A., Wong K., Cachat J., Gaikwad S., Kyzar E., Wu N., Hart P., Piet V., Utterback E. M. Elegante and others, Zebrafish models to study drug abuse-related phenotypes. Rev. Neurosci. 2011, 22(1):95-105.
76. Strahle U., Grabher C. The zebrafish embryo as a model for assessing off-target drug effects. Dis Model Mech 2010, 3:689-692.
77. Swain H.A., Sigstad C., Scalzo F.M. Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). Neurotoxicol Teratol 2004, 26:725-729.
78. Tang R., Dodd A., Lai D., McNabb W.C., Love D.R. Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochim Biophys Sin (Shanghai) 2007, 39:384-390.
79. Trompouki E., Zon L.I. Small molecule screen in zebrafish and HSC expansion. Methods Mol Biol 2010, 636:301-316.
80. Van Ree J.M., Leys A. Behavioral effects of morphine and phencyclidine in rats: the influence of repeated testing before and after single treatment. Eur J Pharmacol 1985, 113:353-362.
81. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 1996, 16:373-379.
82. Webb K.J., Norton W.H., Trumbach D., Meijer A.H., Ninkovic J., Topp S., et al. Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine. Genome Biol 2009, 10:R81.
83. Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio) 2007, University of Oregon Press, Eugene. Edition.
84. White P.F., Way W.L., Trevor A.J. Ketamine - its pharmacology and therapeutic uses. Anesthesiology 1982, 56:119-136.
85. Williams T.D., Rollins M., Block B.A. Intramuscular anesthesia of bonito and Pacific mackerel with ketamine and medetomidine and reversal of anesthesia with atipamezole. J Am Vet Med Assoc 2004, 225:417-421.
86. Wilson C., Cone K., Kercher M., Hibbitts J., Fischer J., Van Lake A., et al. Naloxone increases ketamine-induced hyperactivity in the open field in female rats. Pharmacol Biochem Behav 2005, 81:530-534.
87. Wilson C., Kercher M., Quinn B., Murphy A., Fiegel C., McLaurin A. Effects of age and sex on ketamine-induced hyperactivity in rats. Physiol Behav 2007, 91:202-207.
88. Wong K., Elegante M., Bartels B., Elkhayat S., Tien D., Roy S., et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 2010, 208:450-457.
89. Wong K., Stewart A., Gilder T., Wu N., Frank K., Gaikwad S., et al. Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. Brain Res 2010, 1348:209-215.
90. Wright D., Krause J. Repeated measures of shoaling tendency in zebrafish (Danio rerio) and other small teleost fishes. Nat Protoc 2006, 1:1828-1831.
91. Wright D., Rimmer L.B., Pritchard V.L., Krause J., Butlin R.K. Inter and intra-population variation in shoaling and boldness in the zebrafish Danio rerio. Naturwissenschaften 2003, 90:374-377.
92. Xi Y., Ryan J., Noble S., Yu M., Yilbas A.E., Ekker M. Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function. Eur J Neurosci 2010, 31:623-633.
93. Zakhary S.M., Ayubcha D., Ansari F., Kamran K., Karim M., Leheste J.R., et al. A behavioral and molecular analysis of ketamine in zebrafish. Synapse 2011, 65:160-167.
94. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006, 63:856-864.